Foundation Medicine, Inc.·4

Jul 5, 4:08 PM ET

Fiedler Konstantin 4

4 · Foundation Medicine, Inc. · Filed Jul 5, 2018

Insider Transaction Report

Form 4
Period: 2018-07-02
Fiedler Konstantin
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2018-07-02$136.66/sh994$135,84026,835 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
  • [F2]The reporting person previously reported restricted stock units granted to the reporting person on (1) January 1, 2017 in Table I of the Form 3 filed on February 22, 2018 and (2) April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting events related to this securities sale.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION